Neurocrine Biosciences
NBIX
#1279
Rank
$13.49 B
Marketcap
$134.07
Share price
2.45%
Change (1 day)
38.23%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : $1.08 B

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are $1.08 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$1.01 B54.24%
2022-12-31$0.66 B-5.38%
2021-12-31$0.69 B14.79%
2020-12-31$0.60 B-9.06%
2019-12-31$0.66 B30.59%
2018-12-31$0.51 B15.03%
2017-12-31$0.44 B787.2%
2016-12-31$50.2 M-0.24%
2015-12-31$50.33 M46.59%
2014-12-31$34.33 M0.2%
2013-12-31$34.26 M-17.64%
2012-12-31$41.6 M-46.85%
2011-12-31$78.28 M-37.41%
2010-12-31$0.12 B87.06%
2009-12-31$66.86 M-17.87%
2008-12-31$81.4 M-48.46%
2007-12-31$0.15 B110.72%
2006-12-31$74.96 M-19.41%
2005-12-31$93.01 M-25.82%
2004-12-31$0.12 B-23.47%
2003-12-31$0.16 B287.45%
2002-12-31$42.28 M17.6%
2001-12-31$35.95 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$128.53 B 11,732.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$140.82 B 12,863.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.04 B 4,599.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.87 B-19.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.82 M-95.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.43 B-59.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.82 M-99.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.26 B 476.93%๐Ÿ‡ฌ๐Ÿ‡ง UK